371 related articles for article (PubMed ID: 31281320)
1. Structural Basis of IL-1 Family Cytokine Signaling.
Fields JK; Günther S; Sundberg EJ
Front Immunol; 2019; 10():1412. PubMed ID: 31281320
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
Fields JK; Kihn K; Birkedal GS; Klontz EH; Sjöström K; Günther S; Beadenkopf R; Forsberg G; Liberg D; Snyder GA; Deredge D; Sundberg EJ
Front Immunol; 2021; 12():779100. PubMed ID: 35003094
[TBL] [Abstract][Full Text] [Related]
3. IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.
Günther S; Deredge D; Bowers AL; Luchini A; Bonsor DA; Beadenkopf R; Liotta L; Wintrode PL; Sundberg EJ
Immunity; 2017 Sep; 47(3):510-523.e4. PubMed ID: 28930661
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-36: Structure, Signaling and Function.
Zhou L; Todorovic V
Adv Exp Med Biol; 2021; 21():191-210. PubMed ID: 32026417
[TBL] [Abstract][Full Text] [Related]
5. Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling.
Fields JK; Gyllenbäck EJ; Bogacz M; Obi J; Birkedal GS; Sjöström K; Maravillas K; Grönberg C; Rattik S; Kihn K; Flowers M; Smith AK; Hansen N; Fioretos T; Huyhn C; Liberg D; Deredge D; Sundberg EJ
Cell Rep; 2024 May; 43(5):114099. PubMed ID: 38636519
[TBL] [Abstract][Full Text] [Related]
6. Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer.
Zheng P; Zhang Y; Zhang B; Wang Y; Wang Y; Yang L
Biomed Pharmacother; 2018 Nov; 107():1064-1073. PubMed ID: 30257318
[TBL] [Abstract][Full Text] [Related]
7. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.
Gabay C; Towne JE
J Leukoc Biol; 2015 Apr; 97(4):645-52. PubMed ID: 25673295
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
9. The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions.
Zarezadeh Mehrabadi A; Aghamohamadi N; Khoshmirsafa M; Aghamajidi A; Pilehforoshha M; Massoumi R; Falak R
Immunology; 2022 May; 166(1):38-46. PubMed ID: 35231129
[TBL] [Abstract][Full Text] [Related]
10. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
[TBL] [Abstract][Full Text] [Related]
11. A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.
Lu HL; Yang CY; Chen HC; Hung CS; Chiang YC; Ting LP
Mol Immunol; 2008 Mar; 45(5):1374-84. PubMed ID: 17949817
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-1 receptor family.
Boraschi D; Tagliabue A
Semin Immunol; 2013 Dec; 25(6):394-407. PubMed ID: 24246227
[TBL] [Abstract][Full Text] [Related]
13. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
[TBL] [Abstract][Full Text] [Related]
14. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein.
Jensen LE; Muzio M; Mantovani A; Whitehead AS
J Immunol; 2000 May; 164(10):5277-86. PubMed ID: 10799889
[TBL] [Abstract][Full Text] [Related]
15. Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses.
Krumm B; Xiang Y; Deng J
Protein Sci; 2014 May; 23(5):526-38. PubMed ID: 24677376
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
[TBL] [Abstract][Full Text] [Related]
17. The IL-1 family in tumorigenesis and antitumor immunity.
Sun R; Gao DS; Shoush J; Lu B
Semin Cancer Biol; 2022 Nov; 86(Pt 2):280-295. PubMed ID: 35580824
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes.
Banerjee M; Saxena M
Clin Chim Acta; 2012 Aug; 413(15-16):1163-70. PubMed ID: 22521751
[TBL] [Abstract][Full Text] [Related]
19. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
20. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
Martin MU; Wesche H
Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
